Cardiac Amyloidosis: Overcoming the Gap between Recognition and Effective Management
Autor(a) principal: | |
---|---|
Data de Publicação: | 2024 |
Outros Autores: | , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Brazilian Journal of Implantology and Health Sciences |
Texto Completo: | https://bjihs.emnuvens.com.br/bjihs/article/view/1674 |
Resumo: | Introduction: Cardiac amyloidosis (CA) is a rare condition caused by the accumulation of amyloid proteins in the heart, resulting in impaired cardiac function. CA is often underdiagnosed due to its nonspecific clinical presentation and lack of awareness about the disease. This article aims to understand the pathophysiology, diagnosis, and management of CA. Methodology: A systematic review was conducted using databases such as Scielo and PubMed, with the descriptors "Amyloidosis" AND "Cardiovascular System," yielding 3306 studies, of which 23 were selected for better addressing the chosen topic and being published in English or Portuguese. Inclusion and exclusion criteria were applied to ensure the quality of the selected studies. Results: CA can be caused by different types of amyloidosis, with light-chain amyloidosis (AL) and transthyretin amyloidosis (ATTR) being the most common. Symptoms are nonspecific and include dyspnea, fatigue, and edema, often leading to diagnostic errors. Diagnosis involves a combination of methods, including imaging tests and tissue biopsy. Treatment aims to slow disease progression and alleviate symptoms, tailored according to the type and stage of CA. Conclusion: CA represents a diagnostic and therapeutic challenge due to its varied clinical presentation and complexity. Awareness of the signs and symptoms of the disease is crucial for early diagnosis and better patient management. Continuous development of clinical and therapeutic approaches is necessary to optimize outcomes for patients affected by this debilitating condition. |
id |
GOE-1_2e97cc0ca889c543b26cad807202b92d |
---|---|
oai_identifier_str |
oai:ojs.bjihs.emnuvens.com.br:article/1674 |
network_acronym_str |
GOE-1 |
network_name_str |
Brazilian Journal of Implantology and Health Sciences |
repository_id_str |
|
spelling |
Cardiac Amyloidosis: Overcoming the Gap between Recognition and Effective ManagementAmiloidosis cardiaca: Superando la Brecha entre el Reconocimiento y el Manejo EfectivoAMILOIDOSE CARDÍACA: SUPERANDO A LACUNA ENTRE O RECONHECIMENTO E O MANEJO EFETIVOAmiloidose cardíacaDiagnóstico precoceTratamento personalizadoManifestações clínicasManejo terapêuticoCardiac amyloidosisEarly DiagnosisPersonalized TreatmentClinical ManifestationsTherapeutic ManagementIntroduction: Cardiac amyloidosis (CA) is a rare condition caused by the accumulation of amyloid proteins in the heart, resulting in impaired cardiac function. CA is often underdiagnosed due to its nonspecific clinical presentation and lack of awareness about the disease. This article aims to understand the pathophysiology, diagnosis, and management of CA. Methodology: A systematic review was conducted using databases such as Scielo and PubMed, with the descriptors "Amyloidosis" AND "Cardiovascular System," yielding 3306 studies, of which 23 were selected for better addressing the chosen topic and being published in English or Portuguese. Inclusion and exclusion criteria were applied to ensure the quality of the selected studies. Results: CA can be caused by different types of amyloidosis, with light-chain amyloidosis (AL) and transthyretin amyloidosis (ATTR) being the most common. Symptoms are nonspecific and include dyspnea, fatigue, and edema, often leading to diagnostic errors. Diagnosis involves a combination of methods, including imaging tests and tissue biopsy. Treatment aims to slow disease progression and alleviate symptoms, tailored according to the type and stage of CA. Conclusion: CA represents a diagnostic and therapeutic challenge due to its varied clinical presentation and complexity. Awareness of the signs and symptoms of the disease is crucial for early diagnosis and better patient management. Continuous development of clinical and therapeutic approaches is necessary to optimize outcomes for patients affected by this debilitating condition.Introdução: A amiloidose cardíaca (AC) é uma condição rara causada pelo acúmulo de proteínas amiloides no coração, resultando em comprometimento da função cardíaca. A AC é frequentemente subdiagnosticada devido à sua clínica inespecífica e à falta de conscientização sobre a doença. Este artigo visa compreender a fisiopatologia, diagnóstico e manejo da AC. Metodologia: Realizou-se uma revisão sistemática utilizando bases de dados como Scielo e Pubmed, utilizando os descritores “Amyloidosis” AND “Cardiovascular System”, obtendo-se 3306 estudos, dos quais 23 foram selecionados por abordarem melhor o tema escolhido e serem publicados em inglês ou português. Os critérios de inclusão e exclusão foram aplicados para garantir a qualidade dos estudos selecionados. Resultados: A AC pode ser causada por diferentes tipos de amiloidose, sendo a amiloidose de cadeia leve (AL) e a amiloidose associada à transtirretina (ATTR) as mais comuns. Os sintomas são inespecíficos e incluem dispneia, fadiga e edema, levando frequentemente a erros diagnósticos. O diagnóstico envolve uma combinação de métodos, incluindo exames de imagem e biópsia tecidual. O tratamento visa retardar a progressão da doença e aliviar os sintomas, sendo personalizado de acordo com o tipo e estágio da AC. Conclusão: A AC representa um desafio diagnóstico e terapêutico devido à sua apresentação clínica variada e complexidade. A conscientização sobre os sinais e sintomas da doença é crucial para um diagnóstico precoce e um melhor manejo dos pacientes. O desenvolvimento contínuo de abordagens clínicas e terapêuticas é necessário para otimizar os resultados para os pacientes afetados por essa condição debilitante.Specialized Dentistry Group2024-03-16info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://bjihs.emnuvens.com.br/bjihs/article/view/167410.36557/2674-8169.2024v6n3p1388-1401Brazilian Journal of Implantology and Health Sciences ; Vol. 6 No. 3 (2024): BJIHS QUALIS B3; 1388-1401Brazilian Journal of Implantology and Health Sciences ; Vol. 6 Núm. 3 (2024): BJIHS QUALIS B3; 1388-1401Brazilian Journal of Implantology and Health Sciences ; v. 6 n. 3 (2024): BJIHS QUALIS B3; 1388-14012674-8169reponame:Brazilian Journal of Implantology and Health Sciencesinstname:Grupo de Odontologia Especializada (GOE)instacron:GOEporhttps://bjihs.emnuvens.com.br/bjihs/article/view/1674/1883Copyright (c) 2024 Humberto Novais da Conceição, Marina Pezzetti Sanchez Diogo, Debora Glenda dos Santos , Lucas Santana e Silva Maciel, Gabriel Moreira Quadros, Ana Paula França Pedroso , Sophia Orsi , Pedro Emanuel Fonseca de Romero, Vinicius Barros Prehl, Sávio Praxedes Silva de Araújo, Vanessa Aparecida Carvalho Santos de Castro, Lhaura Pryscilla Sousa Oliveira, David Ricardo Bernal Lima Hernandez, Letícia Martins Tostes, Julia Queiroz Pivahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessNovais da Conceição, HumbertoPezzetti Sanchez Diogo, MarinaGlenda dos Santos , DeboraSantana e Silva Maciel, Lucas Moreira Quadros, GabrielPaula França Pedroso , AnaOrsi , SophiaEmanuel Fonseca de Romero, Pedro Barros Prehl, ViniciusPraxedes Silva de Araújo, Sávio Aparecida Carvalho Santos de Castro, Vanessa Pryscilla Sousa Oliveira, LhauraRicardo Bernal Lima Hernandez, DavidMartins Tostes, LetíciaQueiroz Piva, Julia2024-03-16T16:36:45Zoai:ojs.bjihs.emnuvens.com.br:article/1674Revistahttps://bjihs.emnuvens.com.br/bjihsONGhttps://bjihs.emnuvens.com.br/bjihs/oaijournal.bjihs@periodicosbrasil.com.br2674-81692674-8169opendoar:2024-03-16T16:36:45Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE)false |
dc.title.none.fl_str_mv |
Cardiac Amyloidosis: Overcoming the Gap between Recognition and Effective Management Amiloidosis cardiaca: Superando la Brecha entre el Reconocimiento y el Manejo Efectivo AMILOIDOSE CARDÍACA: SUPERANDO A LACUNA ENTRE O RECONHECIMENTO E O MANEJO EFETIVO |
title |
Cardiac Amyloidosis: Overcoming the Gap between Recognition and Effective Management |
spellingShingle |
Cardiac Amyloidosis: Overcoming the Gap between Recognition and Effective Management Novais da Conceição, Humberto Amiloidose cardíaca Diagnóstico precoce Tratamento personalizado Manifestações clínicas Manejo terapêutico Cardiac amyloidosis Early Diagnosis Personalized Treatment Clinical Manifestations Therapeutic Management |
title_short |
Cardiac Amyloidosis: Overcoming the Gap between Recognition and Effective Management |
title_full |
Cardiac Amyloidosis: Overcoming the Gap between Recognition and Effective Management |
title_fullStr |
Cardiac Amyloidosis: Overcoming the Gap between Recognition and Effective Management |
title_full_unstemmed |
Cardiac Amyloidosis: Overcoming the Gap between Recognition and Effective Management |
title_sort |
Cardiac Amyloidosis: Overcoming the Gap between Recognition and Effective Management |
author |
Novais da Conceição, Humberto |
author_facet |
Novais da Conceição, Humberto Pezzetti Sanchez Diogo, Marina Glenda dos Santos , Debora Santana e Silva Maciel, Lucas Moreira Quadros, Gabriel Paula França Pedroso , Ana Orsi , Sophia Emanuel Fonseca de Romero, Pedro Barros Prehl, Vinicius Praxedes Silva de Araújo, Sávio Aparecida Carvalho Santos de Castro, Vanessa Pryscilla Sousa Oliveira, Lhaura Ricardo Bernal Lima Hernandez, David Martins Tostes, Letícia Queiroz Piva, Julia |
author_role |
author |
author2 |
Pezzetti Sanchez Diogo, Marina Glenda dos Santos , Debora Santana e Silva Maciel, Lucas Moreira Quadros, Gabriel Paula França Pedroso , Ana Orsi , Sophia Emanuel Fonseca de Romero, Pedro Barros Prehl, Vinicius Praxedes Silva de Araújo, Sávio Aparecida Carvalho Santos de Castro, Vanessa Pryscilla Sousa Oliveira, Lhaura Ricardo Bernal Lima Hernandez, David Martins Tostes, Letícia Queiroz Piva, Julia |
author2_role |
author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Novais da Conceição, Humberto Pezzetti Sanchez Diogo, Marina Glenda dos Santos , Debora Santana e Silva Maciel, Lucas Moreira Quadros, Gabriel Paula França Pedroso , Ana Orsi , Sophia Emanuel Fonseca de Romero, Pedro Barros Prehl, Vinicius Praxedes Silva de Araújo, Sávio Aparecida Carvalho Santos de Castro, Vanessa Pryscilla Sousa Oliveira, Lhaura Ricardo Bernal Lima Hernandez, David Martins Tostes, Letícia Queiroz Piva, Julia |
dc.subject.por.fl_str_mv |
Amiloidose cardíaca Diagnóstico precoce Tratamento personalizado Manifestações clínicas Manejo terapêutico Cardiac amyloidosis Early Diagnosis Personalized Treatment Clinical Manifestations Therapeutic Management |
topic |
Amiloidose cardíaca Diagnóstico precoce Tratamento personalizado Manifestações clínicas Manejo terapêutico Cardiac amyloidosis Early Diagnosis Personalized Treatment Clinical Manifestations Therapeutic Management |
description |
Introduction: Cardiac amyloidosis (CA) is a rare condition caused by the accumulation of amyloid proteins in the heart, resulting in impaired cardiac function. CA is often underdiagnosed due to its nonspecific clinical presentation and lack of awareness about the disease. This article aims to understand the pathophysiology, diagnosis, and management of CA. Methodology: A systematic review was conducted using databases such as Scielo and PubMed, with the descriptors "Amyloidosis" AND "Cardiovascular System," yielding 3306 studies, of which 23 were selected for better addressing the chosen topic and being published in English or Portuguese. Inclusion and exclusion criteria were applied to ensure the quality of the selected studies. Results: CA can be caused by different types of amyloidosis, with light-chain amyloidosis (AL) and transthyretin amyloidosis (ATTR) being the most common. Symptoms are nonspecific and include dyspnea, fatigue, and edema, often leading to diagnostic errors. Diagnosis involves a combination of methods, including imaging tests and tissue biopsy. Treatment aims to slow disease progression and alleviate symptoms, tailored according to the type and stage of CA. Conclusion: CA represents a diagnostic and therapeutic challenge due to its varied clinical presentation and complexity. Awareness of the signs and symptoms of the disease is crucial for early diagnosis and better patient management. Continuous development of clinical and therapeutic approaches is necessary to optimize outcomes for patients affected by this debilitating condition. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-03-16 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/1674 10.36557/2674-8169.2024v6n3p1388-1401 |
url |
https://bjihs.emnuvens.com.br/bjihs/article/view/1674 |
identifier_str_mv |
10.36557/2674-8169.2024v6n3p1388-1401 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/1674/1883 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Specialized Dentistry Group |
publisher.none.fl_str_mv |
Specialized Dentistry Group |
dc.source.none.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences ; Vol. 6 No. 3 (2024): BJIHS QUALIS B3; 1388-1401 Brazilian Journal of Implantology and Health Sciences ; Vol. 6 Núm. 3 (2024): BJIHS QUALIS B3; 1388-1401 Brazilian Journal of Implantology and Health Sciences ; v. 6 n. 3 (2024): BJIHS QUALIS B3; 1388-1401 2674-8169 reponame:Brazilian Journal of Implantology and Health Sciences instname:Grupo de Odontologia Especializada (GOE) instacron:GOE |
instname_str |
Grupo de Odontologia Especializada (GOE) |
instacron_str |
GOE |
institution |
GOE |
reponame_str |
Brazilian Journal of Implantology and Health Sciences |
collection |
Brazilian Journal of Implantology and Health Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE) |
repository.mail.fl_str_mv |
journal.bjihs@periodicosbrasil.com.br |
_version_ |
1796798446246559744 |